Drug-maker Cipla today reported a 40.41 per cent rise in consolidated net profit to Rs 1,082.59 crore for the year ended March, 2010, compared to Rs 771.02 crore in the previous fiscal.
The company has recommended a dividend of Rs 2 per share of Rs 2 face value for the year 2009-10, which will entail an outgo of Rs 160.58 crore.
Total operating income for the year ended March, 2010, stood at Rs 5,624.91 crore, compared to Rs 5,246.07 crore in the previous fiscal, the company said in a statement.
In March, 2010, the company sold the intellectual property rights and technical know-how for 'i-pill', an emergency contraceptive brand, to Piramal Healthcare for a consideration of Rs 95 crore.
Shares of Cipla today closed at Rs 337.85 on the BSE, down 0.69 per cent from the previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app